Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Antipsychotic, Apomorphine, Bipolar Disorder, Central Nervous System Stimulant, Dopamine, Dopamine Agonist, Drugs, Manic-Depressive Illness, Mental Health, Neurology, ... "Asenapine, a novel psychopharmacologic agent in the development for schizophrenia and bipolar disorder, has high affinity for ...
2009 NOV 28 ... Central Nervous System Stimulant, Clinical Trial Research, Cocaine, Community Health, Dopamine, Epidemiology, Gastroenterology, Gastroschisis, Pediatric, Pharyngitis, Pseudoephedrine, ... mothers need to get proper prenatal care."Keywords: Pediatrics, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Bronchodilator, Central Nervous System Agent, ...
2009 NOV 23 ... We also determined the effects of coadministering these two compounds on MK-801-induced dopamine and norepinephrine efflux in the nucleus accumbens (NAc). At the submaximally effective ... & Company Inc., Pharmaceutical Business, Pharmaceutical Company, Amphetamine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Central Nervous System Stimulant, Dopamine, Olanzapine, ...
2009 NOV 23 ... Drug Event, Adverse Drug Reaction, Amphetamine, Central Nervous System Stimulant, Dopamine, Drugs, Lisdexamfetamine Dimesylate, Omeprazole, Pharmaceuticals, Pharmacokinetics, ... USA. Keywords: City:Wayne, State:PA, Country:United States, Adrenergic Agent, Adrenergic Uptake Inhibitor, Adverse Drug Effect, Adverse Drug Event, Adverse Drug ...
2009 NOV 28 ... to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial ... Country:Netherlands, Country:Netherlands, Life Sciences, Amphetamine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Central Nervous System Stimulant, Dopamine, Haloperidol, ...
2009 NOV 23 ... A new study, '1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by ... Keywords: Poland, Krakow, Schizophrenia Therapy, Addiction Medicine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Antipsychotic, Behavior, Biochemical, Central ...
2009 NOV 16 ... normal rats did not exhibit any contralateral rotation to the grafted side suggestive of dopamine unbalance," wrote Y. Mine and colleagues, Keio University, Medical Department. ... St., Philadelphia, PA 19106-3621, USA. Keywords: Japan, Tokyo, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Behavior, Bioengineering, Biomedical ...
2009 NOV 16 ... beta-carbomethoxy-3 beta-phenyltropane (PR04.MZ) has been developed as dopamine transporter (DAT) ligand for molecular imaging. It contains a terminally fluorinated, ... in vivo Evaluation of [F-18]PR04.MZ in Rodents: A Selective Dopamine Transporter Imaging Agent. Chemmedchem, 2009;4(9):1480-1487). For additional information, contact ...
2009 NOV 16 ... for the potential treatment of obesity, is an oral, sustained-release combination of the dopamine and norepinephrine reuptake antagonist bupropion and the opioid antagonist naltrexone. ... III clinical program reaffirm the efficacy and safety of the drug combination, this agent could be approved and launched to become a market leader in the anti-obesity therapeutic ...
2009 NOV 23 ... is the subject of a report. According to a study from Chile, "Oxidation of dopamine to aminochrome seems to be a normal process leading to aminochrome polymerization to ... of the neurotoxin that induces this cell death? We propose that aminochrome is the agent responsible for the death of dopaminergic neurons containing neuromelanin in individuals ...
2009 NOV 16 ... is a worldwide public health problem for which there are no established treatments. The dopamine transporter (DAT) is suspected as the primary target mediating cocaine's abuse-related ... USA. Keywords: United States, Belmont, Addiction Medicine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Central Nervous System Stimulant, Cocaine, ...
